Report of Foreign Issuer (6-k)
15 Mai 2020 - 12:23PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
6-K
REPORT
OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER
THE
SECURITIES EXCHANGE ACT OF 1934
For
the month of May 2020
Commission
file number: 333-207107
Ehave,
Inc.
(Translation of Registrant’s Name Into English)
18851
NE 29th Ave. Suite 700
Aventura,
FL 33180
(954)
233-3511
(Address
of Principal Executive Offices)
Indicate
by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F [X] Form
40-F [ ]
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): __________
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): __________
Extension
to File Annual Report
Ehave
Inc. (the “Company”) will be relying on the Securities and Exchange Commission’s Order under Section 36 of the
Securities Exchange Act of 1934 Granting Exemptions From Specified Provisions of the Exchange Act and Certain Rules Thereunder
dated March 25, 2020 (Release No. 34-88465) (the “Order”) to delay the filing of its annual report on Form 20-F
due to the circumstances related to COVID-19. In particular, the lockdowns and stay at home orders related to COVID-19 have hampered
management’s ability to collect documents from the prior officers and directors of the Company. The Company believes that
it will be able to file its annual report on or before June 30, 2020.
In
light of the current COVID-19 pandemic, the Company will be including the following Risk Factor in its 2019 20-F, as may
be updated to reflect subsequent events impacting the Company:
We
are unable to predict the impact of COVID-19 on our company.
Our
diagnostic and treatment tools, MegaTeam and Ninja Reflex, are currently used in hospitals and other medical settings. Because
of strain put on hospitals and their resources by treatment of patients with COVID-19, hospitals and other facilities are canceling
or postponing non-emergency treatments which may include the use of our tools for the treatment of ADHD and related illnesses.
Additionally, people are generally avoiding medical facilities except in emergency situations and therefore would not be seeking
to utilize our tools in such a setting. While we do not expect this trend to continue indefinitely, its duration and impact cannot
be quantified at this time and may negatively impact or business as it is related to MegaTeam and Ninja Reflex.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.
|
Registrant:
Ehave, Inc.
|
|
|
|
May
14, 2020
|
By:
|
/s/
Ben Kaplan
|
|
|
Ben
Kaplan
|
|
|
CEO
|
Ehave (PK) (USOTC:EHVVF)
Historical Stock Chart
Von Jan 2025 bis Feb 2025
Ehave (PK) (USOTC:EHVVF)
Historical Stock Chart
Von Feb 2024 bis Feb 2025